Concepedia

Christine C. Cheng

CC

23

Publications

2.8K

Citations

18

H-Index

2004

Active since

Affiliations

Eli Lilly (United States)(Current)

University of Nottingham

Queen's Medical Centre

University of Mississippi

The University of Texas Health Science Center at San Antonio

Christine C. Cheng is an author at Eli Lilly (United States) specializing in medicine, metabolic regulation, and metabolism.

Top concepts

MedicineMetabolismMetabolic RegulationHealthPhysiologyCell BiologyMetabolic SyndromePharmacologyEndocrinologyCell Signaling

Publications per year

2004–2023

23

Publications

23

An FGF21-Adiponectin-Ceramide Axis Controls Energy Expenditure and Insulin Action in Mice

William L. Holland, Andrew C. Adams, Joseph T. Brozinick et al. · Cell Metabolism · 2013 · 522 citations · Full text

Obesity, Metabolic Syndrome, Energy Homeostasis +11

The breadth of FGF21's metabolic actions are governed by FGFR1 in adipose tissue

Andrew C. Adams, Chaofeng Yang, Tamer Coşkun et al. · Molecular Metabolism · 2012 · 256 citations · Full text

Interplay between FGF21 and insulin action in the liver regulates metabolism

Brice Emanuelli, Sara G. Vienberg, Graham Smyth et al. · Journal of Clinical Investigation · 2014 · 238 citations · Full text

Brown Fat, Fatty Liver Disease, Insulin Signaling +22

Fibroblast Growth Factor 21 Mediates Specific Glucagon Actions

Kirk M. Habegger, Kerstin Stemmer, Christine C. Cheng et al. · Diabetes · 2013 · 237 citations · Full text

Cell Growth, Cellular Physiology, Insulin Signaling +24

GIPR agonism mediates weight-independent insulin sensitization by tirzepatide in obese mice

Ricardo J. Samms, Michael E. Christe, Kyla Collins et al. · Journal of Clinical Investigation · 2021 · 204 citations · Full text

Rows per page

1–5 of 23